Literature DB >> 1392914

Should clofibrate still be prescribed?

M G Dunnigan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392914      PMCID: PMC1883124          DOI: 10.1136/bmj.305.6850.379

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  9 in total

1.  Should there be a moratorium on the use of cholesterol lowering drugs?

Authors:  G Davey Smith; J Pekkanen
Journal:  BMJ       Date:  1992-02-15

Review 2.  Estrogen and coronary heart disease in women.

Authors:  E Barrett-Connor; T L Bush
Journal:  JAMA       Date:  1991-04-10       Impact factor: 56.272

3.  The cholesterol controversy.

Authors:  J A Tobert
Journal:  BMJ       Date:  1992-03-14

4.  The cholesterol controversy.

Authors:  J P Reckless
Journal:  BMJ       Date:  1992-03-14

Review 5.  Hormone replacement treatment.

Authors:  P Belchetz
Journal:  BMJ       Date:  1989-06-03

6.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Authors:  M F Muldoon; S B Manuck; K A Matthews
Journal:  BMJ       Date:  1990-08-11

7.  Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

Authors:  L A Carlson; G Rosenhamer
Journal:  Acta Med Scand       Date:  1988

8.  Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.

Authors:  R H Bradford; C L Shear; A N Chremos; C Dujovne; M Downton; F A Franklin; A L Gould; M Hesney; J Higgins; D P Hurley
Journal:  Arch Intern Med       Date:  1991-01

Review 9.  Estrogen replacement therapy: an overview.

Authors:  D R Mishell
Journal:  Am J Obstet Gynecol       Date:  1989-12       Impact factor: 8.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.